Status:
COMPLETED
GENSARC 2008 : Medical Economic Evaluation of the Molecular Detection by FISH (Fluorescent in Situ Hybridization) and by PCR (Polymerase Chain Reaction) of Sarcomas Specific Translocations and Amplifications .
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Collaborating Sponsors:
National Cancer Institute, France
Conditions:
Sarcoma
Eligibility:
All Genders
Brief Summary
The clinical and histological diagnosis of sarcomas is often very difficult. The identification of chromosomal and molecular anomalies, such as amplifications, deletions or fusion genes is a powerful ...
Eligibility Criteria
Inclusion
- patients with biopsy or excision of sarcoma (suspected or diagnosed)
- sampling reviewed by pathologists
- frozen sampling
- clinical data available
Exclusion
- opposition of patient
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT00847691
Start Date
March 1 2009
End Date
July 1 2012
Last Update
December 18 2012
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Departement de Pathologie de l'Institut Bergonié
Bordeaux, France, 33076
2
Laboratoire de Biochimie et Biologie Moléculaire, CHRU de Lille
Lille, France, 59037
3
Département d'Anantomie et de Cytologie Pathologie, Centre Léon Berard
Lyon, France, 69373
4
Laboratoire de Génétique des Tumeurs Solides
Nice, France, 06000